Overexpression of Pyruvate Dehydrogenase Kinase 3 Increases Drug Resistance and Early Recurrence in Colon Cancer
- 30 September 2011
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 179 (3), 1405-1414
- https://doi.org/10.1016/j.ajpath.2011.05.050
Abstract
No abstract availableKeywords
Funding Information
- National Research Program of Genome Medicine (NSC99-3112-B-006-010)
- NCKU (A0123)
This publication has 26 references indexed in Scilit:
- Systemic Treatment of Colorectal CancerGastroenterology, 2008
- Cellular life span and the Warburg effectExperimental Cell Research, 2008
- Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancerCellular and Molecular Life Sciences, 2007
- Prostaglandin E2 Induces Fibroblast Growth Factor 9 via EP3-Dependent Protein Kinase Cδ and Elk-1 SignalingMolecular and Cellular Biology, 2006
- HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxiaCell Metabolism, 2006
- HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumptionCell Metabolism, 2006
- Transcriptional repression of human cad gene by hypoxia inducible factor-1Nucleic Acids Research, 2005
- Pyruvate Dehydrogenase and Pyruvate Dehydrogenase Kinase Expression in Non Small Cell Lung Cancer and Tumor-Associated StromaNeoplasia, 2005
- Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes.Diabetes, 1999
- Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complexBiochemical Journal, 1998